21172 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA Virus
Infectious bronchitis virus (IBV) spike protein as subunit vaccine
#302Replication-defective arenavirus vectors
#303Replication deficient influenza virus for the expression of heterologous sequences
#304Modified influenza virus for monitoring and improving vaccine efficiency
#305Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#306Aluminum compounds for use in therapeutics and vaccines
#307Influenza virus reassortment
#308Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#309Method for reducing DNA impurities in viral compositions
#310Lentiviral vector based immunological compounds against malaria
#311METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
#312Modified human hepatitis C virus genomic RNA that can be autonomously replicated
#313Recombinant proteins of and pharmaceutical compositions therefrom
#314Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
#315Reverse genetics methods for virus rescue
#316Modified influenza virus for monitoring and improving vaccine efficiency
#317Vectors and methods for long-term immune evasion to prolong tranplant viability
#318Lentiviral gene transfer vectors and their medicinal applications
#319Vaccinia virus mutants containing the major genomic deletions of MVA
#320METHOD FOR THE PREPARATION OF AN INFLUENZA VIRUS
#321Reverse genetics systems
#322Methods and compositions for eliciting an immune response against hepatitis B virus
#323Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320
#324Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#325REOVIRUS COMPOSITIONS AND METHODS OF USE
#326Influenza viruses and uses thereof
#327Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#328Anti-HIV peptides and methods of use thereof
#329PROCESS FOR PREPARING AN INFLUENZA SEED VIRUS FOR VACCINE MANUFACTURE
#330Human bocavirus and methods of diagnosis and treatment
#331Chimaeric protein
#332Papilloma Pseudovirus and Preparation
#333BOVINE HERPESVIRUS VACCINE
#334Recombinant influenza viruses for vaccines and gene therapy
#335Liquid viral formulations
#336Influenza hemagglutinin and neuraminidase variants
#337Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#338Method for prophylaxis of influenza using vaccine for intranasal administration
#339Recombinant newcastle disease viruses useful as vaccines or vaccine vectors
#340Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
#341Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#342Modified HIV-1 Envelope Proteins
#343Seneca valley virus based compositions and methods for treating disease
#344Circovirus sequences associated with piglet weight loss disease (PWD)
#345Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#346MARKED BOVINE VIRAL DIARRHEA VIRUS VACCINES
#347Circovirus sequences associated with piglet weight loss disease (PWD)
#348Hepatitis C virus expressing reporter tagged NS5A protein
#349Nucleic acid derived from hepatitis C virus and expression vector, transformed cell, and hepatitis C virus particles each prepared by using the same
#350CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
#351Flavivirus host-range mutations and uses thereof
#352Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
#353Reverse genetics of negative-strand RNA viruses in yeast
#354ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS
#355Recombinant influenza vectors with tandem transcription units
#356Efficient cell culture system for hepatitis C virus genotype 7a
#357RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS
#358Generation of virus-like particles and use as panfilovirus vaccine
#359FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#360Recombinant vaccinia virus having hepatitis C virus gene
#361High growth reassortant influenza A virus
#362VACCINE COMPOSITIONS
#363Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#364PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF
#365Immunization compositions and methods
#366Alphavirus and alphavirus replicon particle formulations and methods
#367Immunogenic Influenza Composition
#368Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
#369Avian reoviridae and vaccines thereof
#370RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#371INFECTIOUS CLONES
#372Circovirus sequences associated with piglet weight loss disease (PWD)
#373Vaccine formulations comprising saponin-containing adjuvants
#374Recombinant Rift Valley fever (RVF) viruses and methods of use
#375VIRAL VECTORS FOR DELIVERING VACCINES FOR HIV AND OTHER INFECTIOUS DISEASES
#376High titer recombinant influenza viruses with enhanced replication in vero cells
#377Modified influenza virus for monitoring and improving vaccine efficiency
#378MVA expressing modified HIV envelope, gag, and pol genes
#379Avian Astrovirus
#380Compositions and methods for preventing or treating a viral infection
#381VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION
#382COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS
#383Recombinant avian paramyxovirus vaccine and method for making and using thereof
#384INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#385Post release modification of viral envelopes
#386Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
#387Efficient cell culture system for hepatitis C virus genotype 1A and 1B
#388Efficient cell culture system for hepatitis C virus genotype 6A
#389HIV POLYNUCLEOTIDES AND POLYPEPTIDES DERIVED FROM BOTSWANA MJ4
#390Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#391Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#392Production methods
#393Circovirus sequences associated with piglet weight loss disease (PWD)
#394CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
#395Efficient cell culture system for hepatitis C virus genotype 5A
#396ANTI-MEASLES CANCER IMMUNOTHERAPY
#397Vaccine Production For Pathogenic Bird Viral Diseases
#398Proteins derived from white spot syndrome virus and uses thereof
#399Modified influenza virus
#400Methods of delivery of exogenous proteins to the cytosol and uses thereof
#401Synthetic glucopyranosyl lipid adjuvants
#402Replication-defective arenavirus vectors
#403Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications
#404Lentiviral gene transfer vectors and their medicinal applications
#405Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#406METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#407Reoviruses
#408PRRSV compositions
#409Filovirus vectors and noninfectious filovirus-based particles
#410Papilloma pseudovirus and preparation
#411Chimeric sindbis-eastern equine encephalitis virus and uses thereof
#412Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38
#413NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#414Recombinant baculovirus vaccine
#415Tissue culture system for production of hepatitis C virus
#416CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#417Circovirus sequences associated with piglet weight loss disease (PWD)
#418CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#419EFFICIENTLY REPLICABLE HEPTITIS C VIRUS MUTANT, A HEPTITIS C VIRUS MUTANT COMPRISING REPORTER GENE, A METHOD OF PREPARING OF HCV VACCINE USING THE SAME AND A METHOD OF SCREENING ANTI HCV COMPOSITION USING THE SAME
#420Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#421CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#422CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#423Recoding method that removes inhibitory sequences and improves HIV gene expression
#424CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#425Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
#426CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#427Circovirus sequences associated with piglet weight loss disease (PWD)
#428CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#429CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#430CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#431CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#432METHODS AND COMPOSITIONS IN THE TREATMENT OF PORCINE CIRCOVIRAL INFECTION
#433Non-M, non-O HIV-1 strains, fragments and uses
#434Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor
#435CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#436Infectious clones
#437METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS FOR PROPAGATING VIRUS
#438CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#439Permissive cells and uses thereof
#440ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#441Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
#442Generation of virus-like particles and use as panfilovirus vaccines
#443Papillomavirus vaccines
#444Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PPRS) virus and uses thereof
#445NOVEL INSERTION SITES IN POX VECTORS
#446Chimeric pestiviruses
#447REPLICATION DEFICIENT INFLUENZA VIRUS FOR THE EXPRESSION OF HETEROLOGOUS SEQUENCES
#448LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES
#449Seneca Valley virus based compositions and methods for treating disease
#450Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
#451PRODUCTION OF POXVIRUSES WITH ADHERENT OR NON ADHERENT AVIAN CELL LINES
#452Materials and methods for immunizing against FIV infection
#453METHOD AND DEVICE FOR PRODUCING VACCINE
#454Modified human immunodeficiency virus clade C envelope polypeptides obtained from a zambian isolate
#455Filovirus vectors and noninfectious filovirus-based particles
#456Circovirus sequences associated with piglet weight loss disease (PWD)
#457DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES
#458Infectious, Chimeric Hepatitis C Virus, Methods of Producing the Same and Methods of Use Thereof
#459bacterin vaccine
#460H3 equine influenza A virus
#461Reovirus compositions and methods of use
#462Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle
#463Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#464METHODS OF VACCINE ADMINISTRATION
#465HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
#466Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#467VACCINE FOR IN OVO INOCULATION
#468Medium supplement for virus production
#469PCV2 MYCOPLASMA HYOPNEUMONIAE IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#470Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320
#471Adjuvant viral particle
#472RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#473SEQUENCE ANALYSIS OF THE TETRAVALENT ROTAVIRUS VACCINE
#474Methods of Producing Influenza Vaccine Compositions
#475Production of poxviruses with adherent or non adherent avian cell lines
#476RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS
#477METHODS AND COMPOSITIONS FOR ADENO-ASSOCIATED VIRUS (AAV) WITH HI LOOP MUTATIONS
#478HIV polynucleotides and polypeptides derived from Botswana MJ4
#479Methods for the propagation of modified influenza viruses in embryonated eggs
#480VERO CELL LINE WHICH IS ADAPTED TO GROW IN SUSPENSION
#481N protein of a virus of the paramyxoviridae family-protein of interest fusion proteins
#482Hepatitis C virus non structural fusion protein
#483Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
#484Method for propagating influenza virus
#485Modified human hepatitis C virus genomic RNA that can be autonomously replicated
#486Influenza Hemagglutinin And Neuraminidase Variants
#487VACCINIA VIRUS HOST RANGE GENES TO INCREASE THE TITER OF AVIPOXVIRUSES
#488Circovirus sequences associated with piglet weight loss disease (PWD)
#489Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
#490Compositions and Methods for Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes
#491Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#492Circovirus sequences associated with piglet weight loss disease (PWD)
#493Feline cell capable of being cultured without animal-derived protein, and method for producing virus and method for producing vaccine using thereof
#494VACCINE PRODUCTION FOR PATHOGENIC BIRD VIRAL DISEASES
#495Circovirus sequences associated with piglet weight loss disease (PWD)
#496Canine respiratory coronavirus (CRCV) spike protein
#497TUMOR THERAPY WITH NON-VIRAL-BASED HIGH AFFINITIY LAMININ RECEPTOR-TARGETED VECTORS
#498Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#499METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES
#500Immunogenic compositions and methods
#501TUMOR THERAPY WITH HIGH AFFINITY LAMININ RECEPTOR-TARGETED VECTORS AND COMPOUNDS
#502Vero cell-based influenza virus strains and vaccines
#503MVA expressing modified HIV envelope, gag, and pol genes
#504Proteins derived from white spot syndrome virus and uses thereof
#505Recombinant negative strand RNA virus expression systems and vaccines
#506Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
#507Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#508Alphavirus and Alphavirus Replicon Particle Formulations and Methods
#509RECOVERY OF VIRUS FROM CELL CULTURE USING HYPERTONIC SALT SOLUTION
#510TUMOR THERAPY WITH HIGH AFFINITY LAMININ RECEPTOR-TARGET VECTORS AND COMBINATIONS WITH CHEMOTHERAPEUTIC AGENTS
#511Enhancement of immune response to vaccine by interferon alpha
#512Viral Vectors
#513In vitro model for hepatitis c virion production
#514Marked Bovine Viral Diarrhea Virus Vaccines
#515Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition
#516Human and methods of diagnosis and treatment
#517Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
#518Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
#519Assay for porcine circovirus production
#520Circovirus sequences associated with piglet weight loss disease (PWD)
#521Compositions and methods for preventing or treating a viral infection
#522Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle
#523Method for producing storage stable viruses and immunogenic compositions thereof
#524Means and methods for producing adenovirus vectors
#525Immunostimulatory Compositions
#526Method for Replicating Influenza Virus in Culture
#527Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#528Pneumovirus NS proteins antagonize the interferon IFN response
#529Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same
#530Tumor therapy with high affinity laminin receptor-targeted vectors
#531cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses
#532Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
#533Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof
#534Novel Infectious Burasal Disease Virus And Vaccine Containing Said Virus
#535Composition comprising iscom particles and live micro-organisms
#536Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#537Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes
#538Antigen imitating extracellular areas of membrane proteins of type III produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof
#539Production of viruses, viral isolates and vaccines
#540Novel Atypical Pneumonia-Causing Virus
#541Membrane virus host range mutations and their uses as vaccine substrates
#542Cloned genomes of infectious hepatitis C viruses and uses thereof
#543Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same
#544Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#545Infectious recombinant paramyxovirus from antigenomic cDNA
#546Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#547Preparation of purified exosomes comprising HCV RNA
#548Circovirus sequences associated with piglet weight loss disease (PWD)
#549Canine respiratory coronavirus (CRCV) spike protein, polymerase and hemagglutinin/esterase
#550High titer recombinant influenza viruses for vaccines
#551Targeting adenoviral vectors to dendritic cells
#552Method of preparing a PRRS virus vaccine
#553Use of vaccines for the treatment/prevention of the transmission of pathogens
#554Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#555Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#556Non-M, non-O HIV-1 strains, fragments and uses
#557Methods of Producing Influenza Vaccine Compositions
#558Cloned genome of infectious hepatitis C virus of genotype 2A and uses thereof
#559Chicken RNA polymerase I promoter and the use thereof
#560bacterin vaccine
#561Antigens encoded by alternative reading frames from pathogenic viruses
#562Methods to culture circovirus
#563HPV CD8+ T-cell epitopes
#564Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#565Vero cell line adapted to grow in suspension
#566Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
#567Circovirus sequences associated with piglet weight loss disease (PWD)
#568Hiv polynucleotides and polypeptides derived from botswana mj4
#569Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
#570Circovirus sequences associated with piglet weight loss disease (PWD)
#571Circovirus sequences associated with piglet weight loss disease (PWD)
#572Circovirus sequences associated with piglet weight loss disease (PWD)
#573Circovirus sequences associated with piglet weight loss disease (PWD)
#574Circovirus sequences associated with piglet weight loss disease (PWD)
#575Circovirus sequences associated with piglet weight loss disease (PWD)
#576Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#577Modified influenza virus for monitoring and improving vaccine efficiency
#578Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
#579Diagnostic test kits
#580Peptide epitope-based vaccine for treating Herpes Simplex Virus infections and related diseases
#581Self-assembling recombinant papillomavirus capsid proteins
#582Attenuated circovirus
#583Assay for porcine circovirus production
#584Self-replicating RNA molecule from hepatitis C virus
#585Production of poxviruses with adherent or non adherent avian cell lines
#586bacterin vaccine
#587Circovirus sequences associated with piglet weight loss disease (PWD)
#588Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
#589Method for isolating hepatitis C virus peptides
#590Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
#591Immunogenic compositions comprising
#592Treatment of T cell disorders
#593Virus vectors and methods of making and administering the same
#594Virus vectors and methods of making and administering the same
#595Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#596Recombinant influenza vectors with tandem transcription units
#597Chimeric GB virus B (GBV-B)
#598Insertion sites in fowlpox vectors
#599Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents
#600Seneca Valley virus based compositions and methods for treating disease